| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |